Therapy of hypertensive heart disease: vasodilator agents in the forefront
Bolli, P.; Bühler, F.R.
Therapeutische Umschau. Revue Therapeutique 41(2): 150-155
1984
ISSN/ISBN: 0040-5930 PMID: 6200947 Accession: 044796472
Full-Text Article emailed within 1 workday
Payments are secure & encrypted
References
Selchau, M. 1970: Angiotics. 48. I. Hypertensive agents. II. Hypotensive agents. 3. Vasodilator agents. IV. Agents for the treatment of lipid metabolism disorders Pharmazeutische Praxis 9: 200Just, H.; Drexler, H.; Holubarsch, C. 1988: Therapy of heart failure with vasodilator agents Zeitschrift für Kardiologie 77(Suppl 5): 97-101
Zähringer, J.; Schultheiss, H.P. 1986: Therapy of chronic heart failure with vasodilator agents Der Internist 27(5): 315-321
Nemirovskaia, M.A.; Zharov, E.I.; Vertkin, A.L. 1989: Effect of vasodilator agents on the effectiveness of the complex treatment of patients with ischemic heart disease and congestive heart failure Kardiologiia 29(4): 37-40
Just, H. 1987: Treatment of heart failure: status of therapy with vasodilator agents Herz 12(Suppl 1): 22-26
Just, H.; Drexler, H.; Meinertz, T. 1985: Therapy of early and manifest heart failure with vasodilator agents Verhandlungen der Deutschen Gesellschaft für Innere Medizin 91: 139-143
Houghton, J.L.; Prisant, L.M.; Carr, A.A.; Von Dohlen, T.W.; Frank, M.J. 1991: Relationship of left ventricular mass to impairment of coronary vasodilator reserve in hypertensive heart disease American Heart Journal 121(4 Pt 1): 1107-1112
Carson, P.; Ziesche, S.; Johnson, G.; Cohn, J.N. 1999: Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group Journal of Cardiac Failure 5(3): 178-187
Chatterjee, K.; Massie, B.; Rubin, S.; Gelberg, H.; Brundage, B.H.; Ports, T.A. 1978: Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise American Journal of Medicine 65(1): 134-145
Ktsoeva, T.V. 1986: Role of vasodilator agents in the complex treatment of circulatory insufficiency in patients with ischemic heart disease Terapevticheskii Arkhiv 58(5): 127-131
Greenberg, B.H.; Rahimtoola, S.H. 1981: Vasodilator therapy for valvular heart disease JAMA 246(3): 269-272
Yamazaki, H.; Murayama, A. 1984: Vasodilator therapy in ischemic heart disease Journal of Cardiography. Suppl 3: 61-68
Devlin, W.H.; Starling, M.R. 1994: Outcome of valvular heart disease with vasodilator therapy Comprehensive Therapy 20(10): 569-574
Verbrugge, F.H.; Dupont, M.; Finucan, M.; Gabi, A.; Hawwa, N.; Mullens, W.; Taylor, D.O.; Young, J.B.; Starling, R.C.; Tang, W.H.W. 2015: Response and tolerance to oral vasodilator up-titration after intravenous vasodilator therapy in advanced decompensated heart failure European Journal of Heart Failure 17(9): 956-963
Dohi, S.; Matsumoto, M. 1983: Effects of vasodilator and hypertensive agents on intracranial pressure Masui. Japanese Journal of Anesthesiology 32(10): 1193-1197
Cohn, J.N.; Ziesche, S.; Smith, R.; Anand, I.; Dunkman, W.B.; Loeb, H.; Cintron, G.; Boden, W.; Baruch, L.; Rochin, P.; Loss, L. 1997: Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group Circulation 96(3): 856-863
Inai, K. 2015: Can pulmonary vasodilator therapy expand the operative indications for congenital heart disease? International Heart Journal 56 Suppl: S12-S16
Luna-Lopez, R.; Segura de la Cal, T.; Sarnago Cebada, F.; Martin de Miguel, I.; Hinojosa, W.; Cruz-Utrilla, A.; Velazquez, M.T.; Delgado, J.F.; Mendoza, A.; Arribas Ynsaurriaga, F.; Escribano-Subías, P. 2024: Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease Heart 110(5): 346-352
Biesenbach, G.; Zazgornik, J. 1994: High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy Clinical Nephrology 41(4): 211-218
Rose, O.A.; Ebel, A. 1956: Intra-arterial vasodilator agents in the treatment of advanced occlusive arterial disease of the extremities; a preliminary report of a new vasodilator drug, 27 MI Journal of the American Geriatrics Society 4(2): 142-150